DOPAMINE D3 RECEPTOR SELECTIVE ANTAGONISTS/PARTIAL AGONISTS AND USES THEREOF
US Application 18/812,693
Filed on 2024-08-22
Filed on 2024-08-22
BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME
United Kingdom
19714936.2
Filed on 2019-03-18
19714936.2
Filed on 2019-03-18
BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME
Germany
19714936.2
Filed on 2019-03-18
19714936.2
Filed on 2019-03-18
BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME
France
19714936.2
Filed on 2019-03-18
19714936.2
Filed on 2019-03-18
FLUORINATED MU-OPIOID RECEPTOR AGONISTS
US Application 63/452,879
Filed on 2023-03-17
Filed on 2023-03-17
Dual-Target Dopamine D3 (D3R) and -Opioid (MOR) Receptors Ligands as Potentially Safer Analgesics
US Application 63/488,896
Filed on 2023-03-07
Filed on 2023-03-07
Dopamine D3/D2 Receptor Partial Agonists For The Treatment Of Neuropsychiatric Disorders
US Application 63/377,893
Filed on 2022-09-30
Filed on 2022-09-30
SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS
US Application 63/393,035
Filed on 2022-07-28
Filed on 2022-07-28
ANTIBODIES AGAINST FENTANYL AND FENTANYL ANALOGS
US Application 63/181,826
Filed on 2021-04-29
Filed on 2021-04-29
PROTOCOL TO ENHANCE THERAPEUTIC EFFECTS OF TRANSCRANIAL MAGNETIC STIMULATION
US Application 63/286,229
Filed on 2021-12-06
Filed on 2021-12-06